We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

125 hedge funds and large institutions have $34.8M invested in Sanofi Contingent Value Rights in 2014 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 27 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

4% less funds holding

Funds holding: 130 → 125 (-5)

15% less capital invested

Capital invested by funds: $40.7M → $34.8M (-$5.98M)

19% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 27

31% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 16

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
125
Holders Change
-5
Holders Change %
-3.85%
% of All Funds
3.61%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
11
Increased
22
Reduced
27
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GCM
Gruss Capital Management
New York
+$929K
2
PWAM
Park West Asset Management
California
+$864K
3
SM
Scoggin Management
New York
+$743K
4
Brown Advisory
Brown Advisory
Maryland
+$483K
5
Citigroup
Citigroup
New York
+$372K

Top Sellers

Rank Fund Capital Flow
1
ACM
Abrams Capital Management
Massachusetts
-$3.96M
2
SI
Standard Investments
New York
-$819K
3
PI
Putnam Investments
Massachusetts
-$427K
4
AGCJ
Alden Global Capital (Jersey)
Jersey
-$425K
5
WA
Whitebox Advisors
Minnesota
-$360K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
26
Bank of America
North Carolina
$148K +$36K +96,917 +25%
TL
27
TowerView LLC
New York
$140K -$18.6K -50,000 -10%
TA
28
Teton Advisors
New York
$124K – – –
JGC
29
J. Goldman & Co
New York
$124K +$74.3K +200,000 +100%
ACP
30
Andalusian Capital Partners
Connecticut
$115K – – –
Hudson Bay Capital Management
31
Hudson Bay Capital Management
Connecticut
$105K – – –
DAM
32
Deltec Asset Management
New York
$93K -$55.8K -150,000 -33%
Capstone Investment Advisors
33
Capstone Investment Advisors
New York
$93K – – –
BCM
34
Basso Capital Management
Connecticut
$88K +$20.4K +55,000 +25%
GCIA
35
Gabelli & Co Investment Advisers
New York
$88K +$79.5K +213,871 +305%
FRM
36
Fore Research & Management
New York
$75K +$34.2K +92,037 +61%
First Eagle Investment Management
37
First Eagle Investment Management
New York
$73K – – –
RFC
38
Russell Frank Company
Washington
$71K -$74.3K -200,000 -50%
CCP
39
Cyrus Capital Partners
New York
$62K +$74.3K +200,000 New
Goldman Sachs
40
Goldman Sachs
New York
$60K +$7.1K +19,110 +11%
Citadel Advisors
41
Citadel Advisors
Florida
$59K +$68.6K +184,649 New
Morgan Stanley
42
Morgan Stanley
New York
$54K +$51.5K +138,468 +359%
OCM
43
Osterweis Capital Management
California
$53K +$47.6K +128,150 +290%
YCM
44
Yakira Capital Management
Connecticut
$51K – – –
U
45
UBS
Switzerland
$37K +$4.55K +12,252 +11%
ZIG
46
Zuckerman Investment Group
Illinois
$33K -$19 -50 -0%
PP
47
Paloma Partners
Connecticut
$32K – – –
EEG
48
E.E. Geduld
$31K – – –
Wells Fargo
49
Wells Fargo
California
$29K -$1.44K -3,882 -4%
CCA
50
Catalyst Capital Advisors
New York
$24K – – –
1
2
3 4 5

GCVRZ Hedge Fund Activity: Q1 2014 in Review

125 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q1 2014, worth a combined $34.8M — down 15% from $40.7M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of GCVRZ and 11 opened new positions — a net loss of 5 holders — while 27 trimmed existing stakes and 22 added.

The largest buyer was Gruss Capital Management, adding an estimated $929K. The largest seller was Abrams Capital Management, exiting entirely with an estimated $3.96M sold.

  • 125 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q1 2014, down from 130 in Q4 2013.
  • Funds reported $34.8M of Sanofi Contingent Value Rights stock for Q1 2014, down 15% quarter-over-quarter.
  • 11 funds opened new Sanofi Contingent Value Rights positions in Q1 2014 and 16 closed out, a net change of -5 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q1 2014 was Gruss Capital Management, an estimated $929K added.
  • The largest Sanofi Contingent Value Rights seller in Q1 2014 was Abrams Capital Management, an estimated $3.96M sold.

Based on aggregated 13F filings for Q1 2014.